{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T14:35:58Z","timestamp":1793025358885,"version":"4.5.0"},"reference-count":144,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jdiacomp.2025.109232","type":"journal-article","created":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T22:50:14Z","timestamp":1763938214000},"page":"109232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Regenerative medicine approaches for treating diabetes: Current advances and future directions"],"prefix":"10.1016","volume":"40","author":[{"given":"Sanja","family":"Medenica","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dzihan","family":"Abazovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jovana","family":"Vukovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Vojinovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Tomovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Defeudis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Mazzilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zlata","family":"Kovacevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dusan","family":"Djurdjic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Prelevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Abazovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfredi","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Essam M.","family":"Abdelalim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2025.109232_bb0005","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.2522\/ptj.20080020","article-title":"Epidemiology of diabetes and diabetes-related complications","volume":"88","author":"Deshpande","year":"2008","journal-title":"Phys Ther"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0010","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","article-title":"Type 1 diabetes","volume":"383","author":"Atkinson","year":"2014","journal-title":"The Lancet"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0015","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/S0140-6736(18)31320-5","article-title":"Type 1 diabetes","volume":"391","author":"DiMeglio","year":"2018","journal-title":"The Lancet."},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0020","doi-asserted-by":"crossref","first-page":"17016","DOI":"10.1038\/nrdp.2017.16","article-title":"Type 1 diabetes mellitus","volume":"3","author":"Katsarou","year":"2017","journal-title":"Nat Rev Dis Primer."},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0025","doi-asserted-by":"crossref","first-page":"107","DOI":"10.5500\/wjt.v13.i4.107","article-title":"Islet transplantation-immunological challenges and current perspectives","volume":"13","author":"Kabakchieva","year":"2023","journal-title":"World J Transplant"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0030","doi-asserted-by":"crossref","first-page":"15019","DOI":"10.1038\/nrdp.2015.19","article-title":"Type 2 diabetes mellitus","volume":"1","author":"DeFronzo","year":"2015","journal-title":"Nat Rev Dis Primer"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0035","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1016\/S0140-6736(17)31346-6","volume":"389","author":"Department of Error","year":"2017","journal-title":"The Lancet."},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0040","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.2147\/DMSO.S319895","article-title":"A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives","volume":"14","author":"Reed","year":"2021","journal-title":"Diabetes Metab Syndr Obes Targets Ther"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0045","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1080\/17425255.2016.1215427","article-title":"DPP-4 inhibitor plus SGLT-2 inhibitor as combination therapy for type 2 diabetes: from rationale to clinical aspects","volume":"12","author":"Scheen","year":"2016","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0050","doi-asserted-by":"crossref","first-page":"671946","DOI":"10.3389\/fendo.2021.671946","article-title":"Human beta cell regenerative drug therapy for diabetes: past achievements and future challenges","volume":"12","author":"Wang","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0055","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.2337\/dc25-SINT","article-title":"Introduction and methodology: standards of care in diabetes\u20142025","volume":"48","author":"American Diabetes Association Professional Practice Committee","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0060","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.2337\/dc25-S002","article-title":"2. Diagnosis and classification of diabetes: standards of care in diabetes\u20142025","volume":"48","author":"American Diabetes Association Professional Practice Committee","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0065","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S2213-8587(22)00218-2","article-title":"Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study","volume":"10","author":"Gregory","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3800","article-title":"LADA 30th anniversary: a growing form of diabetes with persistent unresolved questions","volume":"40","author":"Lee Jia Jia","year":"2024","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0075","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/ncpendmet0778","article-title":"Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes","volume":"4","author":"Murphy","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0080","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1750-1172-2-12","article-title":"Neonatal diabetes mellitus: a disease linked to multiple mechanisms","volume":"2","author":"Polak","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0085","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.2337\/dc11-0035","article-title":"MODY: History, genetics, pathophysiology, and clinical decision making","volume":"34","author":"Fajans","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0090","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.2337\/diabetes.53.2007.S103","article-title":"Mitochondrial diabetes: Molecular mechanisms and clinical presentation","volume":"53","author":"Maassen","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0095","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1399-5448.2009.00571.x","article-title":"The diagnosis and management of monogenic diabetes in children and adolescents","volume":"10","author":"Hattersley","year":"2009","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0100","doi-asserted-by":"crossref","first-page":"807","DOI":"10.2174\/1573399816666191230114352","article-title":"Monogenic diabetes: genetics and relevance on diabetes mellitus personalized medicine","volume":"16","author":"Sousa","year":"2020","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0105","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.gde.2018.01.005","article-title":"Congenital forms of diabetes: the beta-cell and beyond","volume":"50","author":"Letourneau","year":"2018","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0110","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000354219","article-title":"Diabetes mellitus in neonates and infants: Genetic heterogeneity, clinical approach to diagnosis, and therapeutic options","volume":"80","author":"Rubio-Cabezas","year":"2013","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0115","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00125-019-4822-4","article-title":"Beta cells in type 1 diabetes: mass and function; sleeping or dead?","volume":"62","author":"Oram","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0120","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1007\/s00125-005-1949-2","article-title":"Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration?","volume":"48","author":"Meier","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0125","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/(SICI)1096-9136(199804)15:4<290::AID-DIA570>3.0.CO;2-M","article-title":"Beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in Type 2 diabetes mellitus: the 10-year follow-up of the Belfast Diet Study","volume":"15","author":"Levy","year":"1998","journal-title":"Diabet Med"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0130","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S2213-8587(20)30022-X","article-title":"Inadequate \u03b2-cell mass is essential for the pathogenesis of type 2 diabetes","volume":"8","author":"Weir","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0135","article-title":"Obesity, type 2 diabetes and beta cell failure: an asian perspective","volume":"s1","author":"Saisho","year":"2014","journal-title":"J Mol Genet Med [Internet]"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0140","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2337\/diabetes.52.1.102","article-title":"\u03b2-Cell deficit and increased \u03b2-cell apoptosis in humans with type 2 diabetes","volume":"52","author":"Butler","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0145","doi-asserted-by":"crossref","first-page":"107776","DOI":"10.1016\/j.phrs.2025.107776","article-title":"Inflammatory signaling pathways in pancreatic \u03b2-cell: New insights into type 2 diabetes pathogenesis","volume":"216","author":"Chen","year":"2025","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0150","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12929-016-0303-y","article-title":"Mechanisms of inflammatory responses and development of insulin resistance: how are they interlinked?","volume":"23","author":"Rehman","year":"2016","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0155","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s41586-020-2631-z","article-title":"Immune-evasive human islet-like organoids ameliorate diabetes","volume":"586","author":"Yoshihara","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0160","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1210\/jc.2012-1206","article-title":"Formation of a human \u03b2-cell population within pancreatic islets is set early in life","volume":"97","author":"Gregg","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101477","article-title":"Emerging diabetes therapies: Bringing back the \u03b2-cells","volume":"60","author":"Basile","year":"2022","journal-title":"Mol Metab"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0170","doi-asserted-by":"crossref","first-page":"5417","DOI":"10.3390\/ijms20215417","article-title":"\u03b2-Cell maturation and identity in health and disease","volume":"20","author":"Salinno","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0175","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cell.2007.12.015","article-title":"\u03b2 cells can be generated from endogenous progenitors in injured adult mouse pancreas","volume":"132","author":"Xu","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0180","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.2337\/db08-1651","article-title":"Age-dependent decline in \u03b2-cell proliferation restricts the capacity of \u03b2-cell regeneration in mice","volume":"58","author":"Tschen","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0185","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrendo.2015.9","article-title":"Diabetes mellitus\u2014advances and challenges in human \u03b2-cell proliferation","volume":"11","author":"Wang","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0190","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/nature08894","article-title":"Conversion of adult pancreatic \u03b1-cells to \u03b2-cells after extreme \u03b2-cell loss","volume":"464","author":"Thorel","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0195","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nature07314","article-title":"In vivo reprogramming of adult pancreatic exocrine cells to \u03b2-cells","volume":"455","author":"Zhou","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0200","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nrendo.2013.138","article-title":"The current state of pancreas transplantation","volume":"9","author":"Gruessner","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0205","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.amjmed.2016.02.011","article-title":"Pancreas transplantation: past, present, future","volume":"129","author":"Dholakia","year":"2016","journal-title":"Am J Med"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0210","series-title":"Pancreas Transplantation [Internet]","article-title":"Pancreas transplantation","author":"Pavan Devulapally","year":"2023"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0215","doi-asserted-by":"crossref","first-page":"a015610","DOI":"10.1101\/cshperspect.a015610","article-title":"Pancreas transplantation: solid organ and islet","volume":"4","author":"Mittal","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0220","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1590\/S1679-45082015RW3163","article-title":"Pancreas transplantation: review","volume":"13","author":"Meirelles J\u00fanior","year":"2015","journal-title":"Einstein S\u00e3o Paulo"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0225","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1210\/er.2018-00154","article-title":"Pancreatic islet transplantation in humans: recent progress and future directions","volume":"40","author":"Rickels","year":"2019","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0230","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/TP.0b013e3181b443ae","article-title":"Successful clinical islet isolation using a GMP-manufactured collagenase and neutral protease","volume":"88","author":"Szot","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0235","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1097\/TP.0b013e31819143ec","article-title":"Islet autotransplant outcomes after total pancreatectomy: a contrast to islet allograft outcomes","volume":"86","author":"Sutherland","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/642787","article-title":"Isolation of human islets for autologous islet transplantation in children and adolescents with chronic pancreatitis","volume":"2012","author":"Bottino","year":"2012","journal-title":"J Transplant"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0245","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2337\/diabetes.55.02.06.db04-0195","article-title":"Integrin signaling via RGD peptides and anti-\u03b21 antibodies confers resistance to apoptosis in islets of Langerhans","volume":"55","author":"Pinkse","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0250","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/01.TP.0000128910.41921.4B","article-title":"Procurement of the human pancreas for pancreatic islet transplantation","volume":"78","author":"Lee","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0255","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1046\/j.1600-6143.2003.00351.x","article-title":"Transplantation of cultured islets from two-layer preserved pancreases in type 1 diabetes with anti-CD3 antibody","volume":"4","author":"Hering","year":"2004","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg."},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0260","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.2337\/db05-1333","article-title":"Effect of donor age on function of isolated human islets","volume":"55","author":"Ihm","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0265","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/TP.0b013e31820385e6","article-title":"Influence of donor age on islet isolation and transplantation outcome","volume":"91","author":"Niclauss","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0270","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/00007890-199604150-00010","article-title":"Variables in organ donors that affect the recovery of human islets of Langerhans","volume":"61","author":"Lakey","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0275","doi-asserted-by":"crossref","first-page":"17444","DOI":"10.1073\/pnas.0608141103","article-title":"Correlation between beta cell mass and glycemic control in type 1 diabetic recipients of islet cell graft","volume":"103","author":"Keymeulen","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0280","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S0140-6736(19)31334-0","article-title":"Advances in \u03b2-cell replacement therapy for the treatment of type 1 diabetes","volume":"394","author":"Vantyghem","year":"2019","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0285","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/nrendo.2016.178","article-title":"Clinical pancreatic islet transplantation","volume":"13","author":"Shapiro","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0290","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/nbt1259","article-title":"Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells","volume":"24","author":"D\u2019Amour","year":"2006","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0295","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/nbt.3033","article-title":"Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells","volume":"32","author":"Rezania","year":"2014","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0300","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/s41587-023-02055-5","article-title":"Encapsulated stem cell-derived \u03b2 cells exert glucose control in patients with type 1 diabetes","volume":"42","author":"Keymeulen","year":"2024","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0305","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/tri.13138","article-title":"Defining outcomes for \u03b2-cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA\/EPITA opinion leaders workshop","volume":"31","author":"Rickels","year":"2018","journal-title":"Transpl Int"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0310","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1111\/ajt.16637","article-title":"Ten-year outcomes of islet transplantation in patients with type 1 diabetes: Data from the Swiss-French GRAGIL network","volume":"21","author":"Lablanche","year":"2021","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0315","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S2213-8587(22)00114-0","article-title":"Pancreatic islet transplantation in type 1 diabetes: 20-year experience from a single-centre cohort in Canada","volume":"10","author":"Marfil-Garza","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0320","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/MOT.0000000000000331","article-title":"Long-term outcome after pancreas transplantation: A registry analysis","volume":"21","author":"Gruessner","year":"2016","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0325","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2165\/00002018-200023020-00002","article-title":"Post-transplant malignancy: the role of immunosuppression","volume":"23","author":"Penn","year":"2000","journal-title":"Drug Saf"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0330","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1172\/JCI200423235","article-title":"Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus","volume":"114","author":"Rother","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0335","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11892-008-0031-0","article-title":"Beta-cell failure in type 2 diabetes mellitus","volume":"8","author":"Lencioni","year":"2008","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0340","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1016\/j.neuron.2023.09.009","article-title":"An inhibitory circuit-based enhancer of DYRK1A function reverses Dyrk1a-associated impairment in social recognition","volume":"111","author":"Shih","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0345","article-title":"Small-molecule compounds targeting \u03b2-cell regeneration for diabetes therapy","volume":"182","author":"Wang","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0350","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1267\/ahc.12035","article-title":"TGF-\u03b2 signaling regulates pancreatic \u03b2-cell proliferation through control of cell cycle regulator p27 expression","volume":"46","author":"Suzuki","year":"2013","journal-title":"Acta Histochem Cytochem"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0355","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0092-8674(00)00121-5","article-title":"TGFbeta signaling in growth control, cancer, and heritable disorders","volume":"103","author":"Massagu\u00e9","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0360","article-title":"Novel therapeutic strategies for islet protection and regeneration in diabetes","volume":"9","author":"Zhou","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0365","doi-asserted-by":"crossref","first-page":"123328","DOI":"10.1016\/j.lfs.2024.123328","article-title":"Semaglutide alleviates the pancreatic \u03b2 cell function via the METTL14 signaling and modulating gut microbiota in type 2 diabetes mellitus mice","volume":"361","author":"Luo","year":"2025","journal-title":"Life Sci"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0370","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/s41591-024-03463-z","article-title":"Subcutaneous weekly semaglutide with automated insulin delivery in type 1 diabetes: a double-blind, randomized, crossover trial","volume":"31","author":"Pasqua","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0375","first-page":"283","article-title":"The advent of monoclonal antibodies in the treatment of chronic autoimmune diseases","volume":"31","author":"Bruno","year":"2011","journal-title":"Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0380","article-title":"Evolving antibody therapies for the treatment of type 1 diabetes","volume":"11","author":"Ke","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0385","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.2337\/dc21-2213","article-title":"Immune checkpoint inhibitors and risk of type 1 diabetes","volume":"45","author":"Chen","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0390","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41574-021-00510-4","article-title":"Therapeutic opportunities for pancreatic \u03b2-cell ER stress in diabetes mellitus","volume":"17","author":"Yong","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/0973-3930.41978","article-title":"Is \u03b2-cell failure in type 2 diabetes mellitus reversible?","volume":"28","author":"Jain","year":"2008","journal-title":"Int J Diabetes Dev Ctries"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0400","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2337\/db12-0364","article-title":"Death and dysfunction of transplanted \u03b2-cells: lessons learned from type 2 diabetes?","volume":"63","author":"Potter","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0405","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nri2395","article-title":"Mesenchymal stem cells in health and disease","volume":"8","author":"Uccelli","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0410","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.stem.2009.05.003","article-title":"Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6","volume":"5","author":"Lee","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0415","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3390\/cells8050467","article-title":"Molecular mechanisms responsible for therapeutic potential of mesenchymal stem cell-derived secretome","volume":"8","author":"Harrell","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0420","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.3390\/ijms18091852","article-title":"Mesenchymal stem cell secretome: toward cell-free therapeutic strategies in regenerative medicine","volume":"18","author":"Vizoso","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0425","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/2616807","article-title":"Comparing the therapeutic potential of stem cells and their secretory products in regenerative medicine","volume":"2021","author":"Foo","year":"2021","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0430","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.semarthrit.2020.06.006","article-title":"Assessing the content validity of patient-reported outcome measures in adult myositis: a report from the OMERACT myositis working group","volume":"50","author":"Esfandiary","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0435","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4103\/1673-5374.264455","article-title":"Mesenchymal stem cells secretome: current trends and future challenges","volume":"15","author":"Teixeira","year":"2020","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2019.102615","article-title":"Mesenchymal stem cells ameliorate \u03b2 cell dysfunction of human type 2 diabetic islets by reversing \u03b2 cell dedifferentiation","volume":"51","author":"Wang","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0445","doi-asserted-by":"crossref","first-page":"16","DOI":"10.7603\/s40730-014-0016-3","article-title":"Preliminary evaluation of intravenous infusion and intrapancreatic injection of human umbilical cord blood-derived mesenchymal stem cells for the treatment of diabetic mice","volume":"1","author":"Phan","year":"2014","journal-title":"Biomed Res Ther"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0450","doi-asserted-by":"crossref","first-page":"315ra189","DOI":"10.1126\/scitranslmed.aad4134","article-title":"Type 1 diabetes immunotherapy using polyclonal regulatory T cells","volume":"7","author":"Bluestone","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0455","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1084\/jem.20040139","article-title":"In vitro\u2013expanded antigen-specific regulatory T cells suppress autoimmune diabetes","volume":"199","author":"Tang","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0460","doi-asserted-by":"crossref","first-page":"102289","DOI":"10.1016\/j.jaut.2019.05.017","article-title":"Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes","volume":"103","author":"Tenspolde","year":"2019","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0465","article-title":"Short Report: CAR Tregs mediate linked suppression and infectious tolerance in islet transplantation","author":"Wardell","year":"2024","journal-title":"bioRxiv [Preprint]"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0470","doi-asserted-by":"crossref","first-page":"114994","DOI":"10.1016\/j.celrep.2024.114994","article-title":"Combinatorial genetic engineering strategy for immune protection of stem cell-derived beta cells by chimeric antigen receptor regulatory T cells","volume":"43","author":"Barra","year":"2024","journal-title":"Cell Rep"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0475","article-title":"CAR-engineered T cell therapy as an emerging strategy for treating autoimmune diseases","volume":"11","author":"Vukovic","year":"2024","journal-title":"Front Med [Internet]"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0480","doi-asserted-by":"crossref","first-page":"e2526067","DOI":"10.1001\/jamanetworkopen.2025.26067","article-title":"Donation physician specialists and missed organ donation opportunities","volume":"8","author":"Kramer","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0485","doi-asserted-by":"crossref","first-page":"1517354","DOI":"10.3389\/frtra.2025.1517354","article-title":"Donor after circulatory death in pancreas transplantation: a scoping review of the literature","volume":"4","author":"Chassot","year":"2025","journal-title":"Front Transplant"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0490","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s40259-025-00703-7","article-title":"Islet cell replacement and regeneration for type 1 diabetes: current developments and future prospects","volume":"39","author":"Rech Tondin","year":"2025","journal-title":"BioDrugs"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0495","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1177\/1932296814540611","article-title":"From beta cell replacement to beta cell regeneration","volume":"8","author":"Liu","year":"2014","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0500","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.2337\/diacare.28.11.2673","article-title":"Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study","volume":"28","author":"Peyrot","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0505","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.cmet.2016.09.007","article-title":"Single-cell mass cytometry analysis of the human endocrine pancreas","volume":"24","author":"Wang","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0510","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1007\/s00125-018-4639-6","article-title":"Advances in drug discovery for human beta cell regeneration","volume":"61","author":"Karakose","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0515","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","article-title":"Mechanisms of action and therapeutic application of glucagon-like peptide-1","volume":"27","author":"Drucker","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0520","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.2337\/db14-0153","article-title":"GABA promotes human \u03b2-cell proliferation and modulates glucose homeostasis","volume":"63","author":"Purwana","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0525","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cmet.2015.05.021","article-title":"Osteoprotegerin and denosumab stimulate human beta cell proliferation through inhibition of the receptor activator of NF-\u03baB ligand pathway","volume":"22","author":"Kondegowda","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0530","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.cmet.2015.12.001","article-title":"SerpinB1 promotes pancreatic \u03b2 cell proliferation","volume":"23","author":"El Ouaamari","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0535","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cmet.2012.05.011","article-title":"A VGF-derived peptide attenuates development of type 2 diabetes via enhancement of islet \u03b2-cell survival and function","volume":"16","author":"Stephens","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0540","doi-asserted-by":"crossref","first-page":"1520313","DOI":"10.3389\/fendo.2024.1520313","article-title":"Glucagon-like peptide-1 receptor agonists and type 1 diabetes: a potential game changer?","volume":"15","author":"Resnick","year":"2025","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0545","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.tem.2024.03.006","article-title":"Harnessing beta cell regeneration biology for diabetes therapy","volume":"35","author":"Bourgeois","year":"2024","journal-title":"Trends Endocrinol Metab TEM"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0550","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3892\/br.2022.1555","article-title":"\u03b2 cell regeneration and novel strategies for treatment of diabetes (review)","volume":"17","author":"Ji","year":"2022","journal-title":"Biomed Rep"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0555","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.3390\/cells10092263","article-title":"DYRK1A kinase inhibitors promote \u03b2-cell survival and insulin homeostasis","volume":"10","author":"Barzowska","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0560","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1021\/acs.jmedchem.9b01624","article-title":"Selective DYRK1A inhibitor for the treatment of type 1 diabetes: discovery of 6-azaindole derivative GNF2133","volume":"63","author":"Liu","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0565","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.devcel.2012.05.014","article-title":"Neonatal \u03b2 cell development in mice and humans is regulated by calcineurin\/NFAT","volume":"23","author":"Goodyer","year":"2012","journal-title":"Dev Cell"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0570","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.2337\/db15-1331","article-title":"Inhibition of TGF-\u03b2 signaling promotes human pancreatic \u03b2-cell replication","volume":"65","author":"Dhawan","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0575","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.cmet.2018.12.005","article-title":"Combined inhibition of DYRK1A, SMAD, and trithorax pathways synergizes to induce robust replication in adult human beta cells","volume":"29","author":"Wang","year":"2019","journal-title":"Cell Metab"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0580","doi-asserted-by":"crossref","first-page":"eaaw9996","DOI":"10.1126\/scitranslmed.aaw9996","article-title":"GLP-1 receptor agonists synergize with DYRK1A inhibitors to potentiate functional human \u03b2 cell regeneration","volume":"12","author":"Ackeifi","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0585","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM200007273430401","article-title":"Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen","volume":"343","author":"Shapiro","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0590","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S2213-8587(18)30078-0","article-title":"Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trial","volume":"6","author":"Lablanche","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0595","doi-asserted-by":"crossref","first-page":"100247","DOI":"10.1016\/j.deman.2024.100247","article-title":"Innovative immunotherapies and emerging treatments in type 1 diabetes management","volume":"17","author":"Zarei","year":"2025","journal-title":"Diabetes Epidemiol Manag"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0600","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/stcltm\/szae059","article-title":"Recent progress in modeling and treating diabetes using stem cell-derived islets","volume":"13","author":"Maestas","year":"2024","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0605","article-title":"Diabetes mellitus: classification, mediators, and complications; a gate to identify potential targets for the development of new effective treatments","volume":"168","author":"Antar","year":"2023","journal-title":"Biomed Pharmacother Biomedecine Pharmacother"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0610","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/S0140-6736(17)30058-2","article-title":"Type 2 diabetes","volume":"389","author":"Chatterjee","year":"2017","journal-title":"The Lancet."},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0615","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12967-024-06019-4","article-title":"From bench to bedside: future prospects in stem cell therapy for diabetes","volume":"23","author":"Lu","year":"2025","journal-title":"J Transl Med"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0620","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.stemcr.2015.02.017","article-title":"Efficient generation of NKX6-1+ pancreatic progenitors from multiple human pluripotent stem cell lines","volume":"4","author":"Nostro","year":"2015","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0625","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cell.2014.09.040","article-title":"Generation of functional human pancreatic \u03b2 cells in vitro","volume":"159","author":"Pagliuca","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0630","doi-asserted-by":"crossref","first-page":"16806","DOI":"10.1073\/pnas.0603916103","article-title":"Wnt and TGF-\u03b2 signaling are required for the induction of an in vitro model of primitive streak formation using embryonic stem cells","volume":"103","author":"Gadue","year":"2006","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0635","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.stem.2019.11.011","article-title":"Circadian entrainment triggers maturation of human in vitro islets","volume":"26","author":"Alvarez-Dominguez","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0640","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41587-020-0430-6","article-title":"Targeting the cytoskeleton to direct pancreatic differentiation of human pluripotent stem cells","volume":"38","author":"Hogrebe","year":"2020","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0645","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41556-018-0271-4","article-title":"Recapitulating endocrine cell clustering in culture promotes maturation of human stem-cell-derived \u03b2 cells","volume":"21","author":"Nair","year":"2019","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0650","article-title":"Design considerations for macroencapsulation devices for stem cell derived islets for the treatment of type 1 diabetes","volume":"8","author":"Goswami","year":"2021","journal-title":"Adv Sci Weinh Baden-Wurtt Ger"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0655","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nrd.2016.232","article-title":"Advances in islet encapsulation technologies","volume":"16","author":"Desai","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0660","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.stem.2023.04.002","article-title":"Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes","volume":"30","author":"Hogrebe","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0665","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.716625","article-title":"Immune protection of stem cell-derived islet cell therapy for treating diabetes","volume":"12","author":"Tahbaz","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0670","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.cmet.2021.03.021","article-title":"Human pluripotent stem cell-derived insulin-producing cells: a regenerative medicine perspective","volume":"33","author":"Migliorini","year":"2021","journal-title":"Cell Metab"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0675","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3389\/fendo.2019.00101","article-title":"Endogenous pancreatic \u03b2 cell regeneration: a potential strategy for the recovery of \u03b2 cell deficiency in diabetes","volume":"10","author":"Zhong","year":"2019","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0680","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41586-018-0088-0","article-title":"Pancreas regeneration","volume":"557","author":"Zhou","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0685","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1463-1326.2008.00939.x","article-title":"Relationship between beta-cell mass and diabetes onset","volume":"10","author":"Matveyenko","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0690","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/19382014.2016.1162367","article-title":"Insulin-positive, Glut2-low cells present within mouse pancreas exhibit lineage plasticity and are enriched within extra-islet endocrine cell clusters","volume":"8","author":"Beamish","year":"2016","journal-title":"Islets"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0695","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nature18624","article-title":"Identification of proliferative and mature \u03b2-cells in the islets of Langerhans","volume":"535","author":"Bader","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0700","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1101\/gad.294389.116","article-title":"All mixed up: defining roles for \u03b2-cell subtypes in mature islets","volume":"31","author":"Liu","year":"2017","journal-title":"Genes Dev"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0705","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1007\/s00125-016-3949-9","article-title":"Targeting insulin-producing beta cells for regenerative therapy","volume":"59","author":"Migliorini","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0710","doi-asserted-by":"crossref","first-page":"10335","DOI":"10.3389\/ti.2022.10335","article-title":"Estimation of early graft function using the BETA-2 score following clinical islet transplantation","volume":"35","author":"Lam","year":"2022","journal-title":"Transpl Int"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0715","doi-asserted-by":"crossref","first-page":"12885","DOI":"10.3389\/ti.2024.12885","article-title":"The future of beta cells replacement in the era of regenerative medicine and organ bioengineering","volume":"37","author":"Berishvili","year":"2024","journal-title":"Transpl Int"},{"key":"10.1016\/j.jdiacomp.2025.109232_bb0720","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3390\/biomedicines10030571","article-title":"Approaches to inducing \u03b2-cell regeneration","volume":"10","author":"Levine","year":"2022","journal-title":"Biomedicines"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872725002855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872725002855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T12:03:46Z","timestamp":1766232226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872725002855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":144,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1056872725002855"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2025.109232","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regenerative medicine approaches for treating diabetes: Current advances and future directions","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2025.109232","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109232"}}